Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 3/20 | 0.47 |
| ▸ | TERT | O14746 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 2/20 | 0.47 |
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1683846 | 1.00 | ZDHHC7 (0.53) | ZDHHC7GPR84FFAR1FFAR4DGKA | |
| SCHEMBL16007077 | 1.00 | ZDHHC7 (0.53) | ZDHHC7GPR84FFAR1FFAR4DGKA | |
| SCHEMBL28810689 | 1.00 | ZDHHC7 (0.53) | ZDHHC7GPR84FFAR1FFAR4DGKA | |
| SCHEMBL5809066 | 1.00 | ZDHHC7 (0.53) | ZDHHC7GPR84FFAR1FFAR4DGKA | |
| SCHEMBL5809063 | 1.00 | ZDHHC7 (0.53) | ZDHHC7GPR84FFAR1FFAR4DGKA | |
| SCHEMBL16007079 | 1.00 | ZDHHC7 (0.53) | ZDHHC7GPR84FFAR1FFAR4DGKA | |
| SCHEMBL28233847 | 1.00 | ZDHHC7 (0.53) | ZDHHC7GPR84FFAR1FFAR4DGKA | |
| SCHEMBL1273138 | 1.00 | ZDHHC7 (0.53) | ZDHHC7GPR84FFAR1FFAR4DGKA | |
| SCHEMBL27786702 | 0.95 | ALDH1A1 (0.51) | FFAR1FFAR4HSD17B10FABP4PPARG | |
| SCHEMBL25367237 | 0.89 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1FFAR4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130211033-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | MEURICE R&D ASBL (BE) | 2013-08-15 | — | — | US | claimed |
| US-20240374734-A1 | Immunomodulatory Combinations of Antigen and Drug-Lipid Conjugate | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2024-11-14 | — | — | US | disclosed |
| CN-118215496-A | Immunomodulatory combinations of antigens and drug-lipid conjugates | 集成纳米治疗股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| EP-3941897-A1 | LIPID CONJUGATE PREPARED FROM SCAFFOLD MOIETY | Integrated Nanotherapeutics Inc. (CA) | 2022-01-26 | — | — | EP | disclosed |
| CN-113853368-A | Lipid conjugates prepared from scaffold moieties | 集成纳米治疗股份有限公司 | 2021-12-28 | — | — | CN | disclosed |
| US-20180134680-A1 | METHOD FOR PRODUCING CYCLIC ESTERS | BASF SE (DE) | 2018-05-17 | — | — | US | disclosed |
| US-9018409-B2 | Process for functionalization of unsaturated compounds | MEURICE R&D ASBL (BE) | 2015-04-28 | — | — | US | disclosed |
| US-20130211033-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | MEURICE R&D ASBL (BE) | 2013-08-15 | — | — | US | disclosed |
| US-8173825-B2 | Reacting unsaturated fatty acid or ester with an epoxidation reagent to form a fatty acid epoxide with an oxirane ring, then reacting with a carboxylic acid to form a hydroxy fatty acid ester derivative where the oxirane ring is opened to form a hydroxy ester; mild conditions, high yield, catalyst free | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2012-05-08 | — | — | US | disclosed |
| US-20110126325-A1 | RECOMBINANT CELLS AND METHODS FOR HYDROXYLATING FATTY ACIDS | COMMONWEALTH SCIENTIFIC INDUSTRIAL RESEARCH ORGANISATION | 2011-05-26 | — | — | US | disclosed |
| EP-2283137-A1 | RECOMBINANT CELLS AND METHODS FOR HYDROXYLATING FATTY ACIDS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2011-02-16 | — | — | EP | disclosed |
| WO-2009129583-A1 | RECOMBINANT CELLS AND METHODS FOR HYDROXYLATING FATTY ACIDS | COMMONWEALTH SCIENTIFIC INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-29 | — | — | WO | disclosed |
| US-20090186761-A1 | Use of bio-derived surfactants for mitigating damage to plants from pests | CLEARESO, LLC | 2009-07-23 | — | — | US | disclosed |
| WO-2008079901-A2 | METHOD OF MAKING FATTY ACID ESTER DERIVATIVES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2008-07-03 | — | — | WO | disclosed |
| US-20080154053-A1 | Method of making fatty acid ester derivatives | THE UNITES STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134680-A1 | METHOD FOR PRODUCING CYCLIC ESTERS | OR51E2, HSD17B12, OR10J3 | ZDHHC7 561/4885GPR84 1371/4885FFAR1 361/4885 |
| US-20130211033-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | F10, RPP30, PUF60 | ZDHHC7 2124/4885GPR84 808/4885FFAR1 301/4885 |
| US-20090186761-A1 | Use of bio-derived surfactants for mitigating damage to plants from pests | SGMS2, SGMS1, PHOSPHO1 | ZDHHC7 435/4885GPR84 1232/4885FFAR1 760/4885 |
| US-20240374734-A1 | Immunomodulatory Combinations of Antigen and Drug-Lipid Conjugate | LY96, CD74, TLR9 | ZDHHC7 689/4885GPR84 1449/4885FFAR1 1614/4885 |
| US-20080154053-A1 | Method of making fatty acid ester derivatives | FASN, ALOX5, ELOVL1 | ZDHHC7 167/4885GPR84 671/4885FFAR1 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.